Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

New Leadership and More Resources Aim to Modernize FDA Operations

Mar 19, 2009

Instead of protecting the public from unsafe drugs and contaminated foods, the Food and Drug Administration is a "hazard to public health," stated President Barack Obama in announcing his choices to head the agency and new efforts to improve food safety. Margaret Hamburg will be FDA's new commissioner, and Joshua Sharfstein principal deputy commissioner for drugs and medical products.

A Call for Transparency in Research and Marketing

Broader disclosure of drug prices and conflicts of interest are central healthcare reform issues.
Mar 2, 2009

Broader disclosure of drug prices and conflicts of interest are central healthcare reform issues.

Congress Approves Down Payment on Health Reform

The stimulus bill expands the healthcare safety net while boosting investment in health IT and comparative research.
Feb 19, 2009

The stimulus bill expands the healthcare safety net while boosting investment in health IT and comparative research.

Drug Prices Remain on the Cutting Board

Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription sales.
Feb 2, 2009

Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription sales.

FDA at a Crossroads

Will more resources and new leadership fix FDA, or is a major overhaul in order?
Jan 2, 2009

Will more resources and new leadership fix FDA, or is a major overhaul in order?

Industry Changes and Challenges

To expand coverage amidst the economic crisis, Obama will look for ways to cut healthcare costs.
Dec 2, 2008

To expand coverage amidst the economic crisis, Obama will look for ways to cut healthcare costs.

How Will the 2008 Election Results Affect the Preemption Debate?

The next president and the 111th Congress might change the extent of FDA's authority.
Dec 2, 2008

The next president and the 111th Congress might change the extent of FDA's authority.

FDA Collaborates on Nanotechnology Research

The US Food and Drug Administration seeks to understand nanotechnology better and exercise appropriate oversight over products that incorporate it.
Nov 2, 2008

The US Food and Drug Administration seeks to understand nanotechnology better and exercise appropriate oversight over products that incorporate it.

Nanotechnology Challenges FDA and Manufacturers

Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.
Nov 2, 2008

Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here